Arcutis Biotherapeutics, Inc. (ARQT) Tops Q1 EPS by 37c

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) reported Q1 EPS of ($0.32), $0.37 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $49.56 million versus the consensus estimate of $14.8 million.

For earnings history and earnings-related data on Arcutis Biotherapeutics, Inc. (ARQT) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Ulta Beauty (ULTA) Tops Q2 EPS by 38c, Offers Outlook
• Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue